Jason J Wilkes

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Chronic endothelin-1 treatment leads to insulin resistance in vivo
    Jason J Wilkes
    Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California, USA
    Diabetes 52:1904-9. 2003
  2. ncbi request reprint Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats
    Jason J Wilkes
    Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, 0673 UCSD, 9500 Gilman Drive, La Jolla, CA 92093, USA
    Am J Physiol Endocrinol Metab 289:E1015-22. 2005
  3. pmc Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance
    Jason J Wilkes
    Department of Cell Biology, Scripps Research Institute, La Jolla, California, USA
    Diabetes 58:1133-43. 2009
  4. ncbi request reprint Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats
    Jason J Wilkes
    Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, USA
    Am J Physiol Endocrinol Metab 288:E617-24. 2005

Detail Information

Publications4

  1. ncbi request reprint Chronic endothelin-1 treatment leads to insulin resistance in vivo
    Jason J Wilkes
    Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California, USA
    Diabetes 52:1904-9. 2003
    ....
  2. ncbi request reprint Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats
    Jason J Wilkes
    Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, 0673 UCSD, 9500 Gilman Drive, La Jolla, CA 92093, USA
    Am J Physiol Endocrinol Metab 289:E1015-22. 2005
    ....
  3. pmc Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance
    Jason J Wilkes
    Department of Cell Biology, Scripps Research Institute, La Jolla, California, USA
    Diabetes 58:1133-43. 2009
    ..A loss-of-function mutation (Mstn(Ln)) in either one or both alleles of the Mstn gene shows how Mstn deficiency protects whole-body insulin sensitivity...
  4. ncbi request reprint Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats
    Jason J Wilkes
    Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, USA
    Am J Physiol Endocrinol Metab 288:E617-24. 2005
    ..Thus the in vivo effects of TPM treatment appear to be exerted through adipose tissue...